ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Quality In Flow (QinFlow) awarded Patient Blood and Fluid Warming agreement with Premier, Inc

By: PRLog

PLANO, Texas - Jan. 24, 2022 - PRLog -- QinFlow Inc. has been awarded a group purchasing agreement for Patient Warming – Blood and Fluid Warming with Premier, Inc. Effective January 15, 2022, the new agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for high performance, aluminum free blood and fluid warming devices for the entire continuum of care.

"We are thrilled that Premier has chosen to award QinFlow a national agreement. This agreement will provide healthcare organizations access to our next-generation blood and IV fluid warming technology, which has been perfected to meet the demanding needs of Emergency Rooms, Trauma Bays, Operating Rooms, and Intensive Care Units," said Ariel Katz, Chief Executive Officer. He added, "This agreement provides an excellent opportunity for hospitals to bridge the supply gap that is associated with recent recalls of aluminum-based warmers as well as the severe shortage of consumables imposed by the pandemic." Mr. Katz concluded that "This agreement between QinFlow and Premier will help accomplish QinFlow's mission to ensure that blood and fluid are warmed prior to administering them to patients so as to combat hypothermia."

The Warrior Modular System offers several configurations, that are optimized to specific hospitals settings. For example, the Warrior Hybrid configuration, that provides both battery and AC power source options, typically serves Emergency Departments and Trauma Bays, while the Warrior AC configuration typically serves Operating Rooms and Intensive Care Units. All Warrior configurations utilize the same Compact Disposable Unit, thus facilitating patient handoff between settings and reducing costs (i.e., the same disposable travels with the patient to the next level of care). The Warrior's key benefits include high performance, immediate warming, unique bolus-flow handling capability, portability, simplicity of operations, nearly zero maintenance (5 years between service calls), and a complete continuum of care proposition, to name just a few.

Premier is a leading healthcare improvement company, uniting an alliance of more than 4,400 U.S. hospitals and 225,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and consulting and other services, Premier enables better care and outcomes at a lower cost.

ABOUT QinFlow

Since 2009 QinFlow (short for Quality in Flow) has worked to develop and perfect a proprietary fluid warming technology (patented) that delivers unparalleled levels of warming efficiency. The company's flagship line of products – the Warrior – provides front-end rescue teams, first responders, critical care transport teams, and emergency care professionals within the hospital with a high performance, reliable, simple to operate, and completely portable blood and IV fluid warming device that operates flawlessly in all environmental conditions in order to fight hypothermia and help in saving lives. QinFlow Inc. is headquartered in Plano Texas. For more information on QinFlow and the Warrior modular system, visit www.qinflow.com. For more information regarding this press release, contact us at info@qinflow.com or at www.qinflow.com/contact/.

Contact
Ariel Katz
***@qinflow.com

Photos: (Click photo to enlarge)

QinFlow Logo

Read Full Story - Quality In Flow (QinFlow) awarded Patient Blood and Fluid Warming agreement with Premier, Inc | More news from this source

Press release distribution by PRLog

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.